Article
Plasminogen activator inhibitor-1 (PAI-1) gene polymorphism (-675 4G/5G) associated with obesity and vascular risk in children.
Journal of pediatric endocrinology & metabolism : JPEM - 1 May 2006
Berberoğlu M, Evliyaoğlu O, Adiyaman P, Ocal G, Ulukol B, Simşek F, Siklar Z, Törel A, Ozel D, Akar N
Abstract excerpt
UNLABELLED: Atherothrombotic complications in insulin resistance are partly attributed to impaired fibrinolysis caused by increased PAI-1 plasma levels, and 4G/5G promotor polymorphism of the PAI-1 gene may modulate PAI-1 transcription. OBJECTIVE: To investigate PAI-1-675 4G/5G allele gene polymorphism and its relationship with obesity in children. CHILDREN AND METHOD: The study participants were 133 apparently...
Topics
- Adult
- Alleles
- Blood Glucose
- Body Mass Index
- Child
- Gene Frequency
- Humans
- Hyperinsulinism
- Insulin
- Metabolic Syndrome
- Obesity
- Odds Ratio
- Plasminogen Activator Inhibitor 1
- Polymorphism, Genetic
